Adenomyosis: The Condition Behind Heavy, Painful Periods That Nobody Told You About

If you have been dealing with periods that are progressively heavier, more painful, and harder to get through every single month — and if your gynaecologist has told you your ultrasound is normal, or "it is just your cycle" — there is a possibility that nobody has looked specifically for adenomyosis.

Adenomyosis is estimated to affect around 20% of women. It is one of the most common causes of severe menstrual pain and heavy bleeding in women in their 30s and 40s. And it is still one of the most frequently missed diagnoses in Indian gynaecology — partly because its symptoms are normalised, partly because the imaging findings are subtle and require specific attention, and partly because the definitive historical diagnosis required removing the uterus entirely.

That last part has changed. Adenomyosis can now be diagnosed with reasonable accuracy on ultrasound and MRI in most cases, without surgery. And it can be managed — non-surgically in many cases — with a range of options that do not involve hysterectomy.

Dr. Shachi Singh, consultant gynaecologist at Prakash Hospital, Sector 33, Noida, explains what adenomyosis actually is, why it happens, how to identify it, and what the treatment options look like.

What Adenomyosis Is

The uterus has two distinct layers: the endometrium (the inner lining that sheds each month as a period) and the myometrium (the thick muscular wall beneath it).

Adenomyosis occurs when tissue from the endometrium — or tissue behaving like endometrium — grows into the myometrium itself. This endometrial tissue within the muscle wall responds to monthly hormonal cycles just as the normal endometrial lining does: it thickens and bleeds. But unlike the lining, which can shed through the cervix, the tissue within the muscle wall has nowhere to go. The blood is trapped. The surrounding muscle reacts with inflammation and scarring. The uterus becomes enlarged, boggy, and tender.

The result, experienced month after month:

• More bleeding than normal, because more endometrial-type tissue is cycling
• More pain than normal, because the muscle wall is contracting against trapped blood and inflammatory tissue
• A progressively enlarging uterus that may become tender to palpation

Adenomyosis can be diffuse — spread throughout the myometrium — or focal, concentrated in one area (sometimes called an adenomyoma, which can be confused on ultrasound with a fibroid).

Why the Symptoms Worsen Over Time

This is one of the distinguishing features of adenomyosis: the symptoms are not static. They worsen progressively over the years. The adenomyotic tissue accumulates. The muscular disruption increases. The inflammatory burden builds. Women with adenomyosis often describe a trajectory: periods that were manageable in their 20s became significantly heavier in the early 30s, and by the mid-30s or 40s, they are passing large clots, changing pads hourly for the first two to three days, and experiencing cramps severe enough to affect work and daily function.

This progressive worsening — particularly in a woman who managed her periods fine for years — is one of the most telling features of the condition.

Who Gets Adenomyosis

Adenomyosis is most commonly diagnosed in women in their 30s and 40s, but it is not confined to this age group. Research increasingly shows it occurs in younger women as well, including adolescents with severe dysmenorrhoea — though historically it was considered a condition of older multiparous women.

Risk factors include:

• Previous uterine surgery: Caesarean section, D&C after miscarriage, myomectomy — any procedure that disrupts the junction between the endometrium and myometrium may allow endometrial tissue to penetrate the muscle wall
• Childbirth: Vaginal delivery, particularly multiple births, may disrupt the endometrial-myometrial boundary
• Co-existing endometriosis: Adenomyosis and endometriosis frequently occur together. Estimates suggest 20 to 35% of women with endometriosis also have adenomyosis, and vice versa
• Family history: There is a genetic component — sisters and daughters of women with adenomyosis have an elevated risk

Symptoms — How Adenomyosis Presents

The classic presentation includes:

Heavy menstrual bleeding (menorrhagia): Periods lasting 7 or more days, passing large clots, soaking through pads or tampons every 1 to 2 hours on heavy days. Many women with adenomyosis are chronically iron-deficient or anaemic as a result.

Severe menstrual cramps (dysmenorrhoea): Pain that begins before the period and intensifies through the first few days. Often described as cramping deep in the pelvis, sometimes radiating to the back and thighs. Many women find that their usual pain relief is no longer effective.

Chronic pelvic pain: Some women experience dull pelvic heaviness or pressure throughout the cycle, not just during menstruation.

Pain during sex (dyspareunia): particularly with deep penetration.

Enlarged, tender uterus: On pelvic examination, the uterus may be enlarged — sometimes two to three times its normal size — and tender on palpation. This is a clinical finding that raises suspicion for adenomyosis.

Bloating: Many women describe abdominal distension, particularly in the premenstrual days and during menstruation.

Not all women have all symptoms. Some have predominantly heavy bleeding with mild pain. Others have severe pain with moderate bleeding. A small number have significant adenomyosis on imaging with surprisingly mild symptoms.

How Adenomyosis Is Diagnosed

This is where the historical difficulty lies. Adenomyosis was traditionally a histological diagnosis — meaning it could only be definitively confirmed by examining the uterine muscle under a microscope after hysterectomy. This is still technically the gold standard for definitive diagnosis, but it is not a practical criterion for diagnosis in women who want to keep their uterus.

Transvaginal Ultrasound (TVUS): A skilled sonographer looking specifically for adenomyosis can identify characteristic findings: heterogeneous (non-uniform) texture of the myometrium, asymmetric myometrial thickening, small myometrial cysts, fan-shaped shadowing, and loss of the normally clear junction between endometrium and myometrium. These features are subtle and may be missed on a standard ultrasound if the sonographer is not specifically evaluating for adenomyosis.

MRI: Provides more detailed and specific imaging of the myometrium. The junctional zone (the boundary between endometrium and myometrium) can be measured precisely on MRI, and thickening of the junctional zone above 12 mm is highly specific for adenomyosis. MRI is more expensive and less routinely available than ultrasound, but adds diagnostic confidence when ultrasound findings are equivocal.

Diagnostic laparoscopy: Cannot directly diagnose adenomyosis (which is within the muscle wall), but can identify coexisting endometriosis and adhesions, and can assess the external uterine surface for characteristic changes.

A clinical diagnosis — based on symptoms, examination findings, and imaging — is what guides treatment in most cases.

Treatment Options for Adenomyosis

Treatment depends on symptom severity, the patient's age, whether she has completed her family, and her preference.

1. Medical Management — The First Line

NSAIDs (Non-steroidal anti-inflammatory drugs): Mefenamic acid, ibuprofen, and similar medications reduce prostaglandin-driven menstrual pain and help reduce bleeding volume to some extent. They are first-line symptomatic treatments but do not address the underlying adenomyosis.

Combined oral contraceptive pill (OCP): Regulates hormonal cycles, reduces endometrial tissue activity, and significantly reduces both bleeding volume and dysmenorrhoea. A practical choice for women who also want contraception.

Progestin-only treatment: Progesterone suppresses endometrial tissue activity. Options include oral progestin tablets, injectable progestins, or the levonorgestrel-releasing IUS (Mirena). The Mirena IUS is considered one of the most effective non-surgical treatments for adenomyosis — it delivers progestin directly to the uterus, often producing very light periods or no periods at all, and significantly reducing pain. Its local delivery means systemic side effects are minimal.

GnRH analogues (gonadotropin-releasing hormone analogues): Injections (monthly or 3-monthly) that temporarily suppress ovarian function, effectively inducing a reversible medical menopause. This suppresses adenomyosis activity dramatically. Used for 3 to 6 months, they can provide significant symptom relief and may shrink the adenomyotic uterus. Not a permanent solution — symptoms typically return after stopping. Used before surgery or as a trial of treatment in complex cases.

Diagnoses: A progestin with a particularly strong suppressive effect on endometrial tissue. Used in several countries specifically for endometriosis and adenomyosis. Growing evidence supports its effectiveness for adenomyosis specifically.

2. Surgical Management

Uterine artery embolisation (UAE): A procedure performed by interventional radiologists that blocks the blood supply to the uterus through the uterine arteries. Reduces bleeding and often shrinks adenomyotic tissue. A non-surgical option for women who want to avoid surgery but are not planning further pregnancies (pregnancy is not recommended after UAE due to placentation concerns).

Focused ultrasound (MRI-guided FUS): A newer non-invasive technique that uses focused ultrasound energy to ablate (destroy) adenomyotic tissue. Available at limited centres in India. Most appropriate for focal adenomyosis in women who have completed their family.

Hysterectomy: The only definitive cure for adenomyosis. When adenomyosis is severe, has not responded to medical management, and the woman has completed her family and is willing to undergo uterine removal, a laparoscopic hysterectomy resolves the condition permanently. The ovaries are generally preserved — removing the uterus alone stops the cyclical hormonal stimulation of the adenomyotic tissue without inducing premature menopause.

Fertility-preserving surgery: Conservative surgical excision of focal adenomyomas is possible in selected cases and is evolving as a technique. However, it is technically demanding and appropriate only in specific presentations. For women with adenomyosis and fertility concerns, management is typically medical (to control symptoms) while fertility treatment proceeds — IVF success rates are generally acceptable in women with adenomyosis with appropriate uterine preparation.

Adenomyosis and Fertility

Adenomyosis can affect fertility and pregnancy outcomes. The mechanisms include impaired uterine contractility affecting embryo transport, altered endometrial receptivity, and the inflammatory uterine environment. The impact varies widely — some women with adenomyosis conceive without difficulty; others have repeated implantation failure.

For women with adenomyosis trying to conceive, management involves:

• Medical suppression with GnRH analogues or dienogest for 3 to 6 months before fertility treatment, which may improve uterine receptivity
• Addressing coexisting endometriosis if present
• Optimising timing with IUI or IVF, depending on the infertility profile

Adenomyosis does not preclude pregnancy, but it warrants proper assessment and management in the fertility context.

Gynaecological Care in Noida and Greater Noida

If you have been dealing with progressively worsening, heavy, painful periods and have not had a specific evaluation for adenomyosis, that evaluation is worth pursuing.

Dr. Shachi Singh at Prakash Hospital, Sector 33, Noida, evaluates and manages adenomyosis for women across Noida and Greater Noida — through targeted ultrasound assessment, hormonal management, Mirena IUS placement, and laparoscopic hysterectomy for women who have completed their family and want definitive resolution.

To book a consultation with Dr. Shachi Singh, call: +91 97023 46853

Clinic Hours: Monday to Saturday, 9 AM – 6 PM | Sunday, 10 AM – 2 PM

Clinic Address: D-12A, 12B, Sector-33, G.B. Nagar, Noida, Uttar Pradesh 201301

Frequently Asked Questions

How is adenomyosis different from endometriosis?

Both involve endometrial-type tissue growing where it should not. In endometriosis, this tissue grows outside the uterus — on the ovaries, tubes, pelvic peritoneum, or bowel. In adenomyosis, it grows within the uterine muscle wall itself. They are different conditions that frequently coexist.

Can adenomyosis be cured without removing the uterus?

Not cured — but managed effectively. Medical treatments (OCP, Mirena IUS, GnRH analogues, progestins) significantly control symptoms in many women. Hysterectomy is the only permanent cure. After menopause, when oestrogen production declines, adenomyosis naturally regresses and symptoms typically resolve.

Does adenomyosis always get worse?

In most women, symptoms are progressive through the reproductive years because the adenomyotic tissue continues accumulating with each menstrual cycle. After menopause, the oestrogen-dependent tissue regresses, and symptoms resolve naturally.

Can I get pregnant with adenomyosis?

Yes, many women with adenomyosis conceive and have healthy pregnancies. The impact on fertility varies. Some women require fertility treatment; medical suppression before IVF may improve outcomes. This is an area where individual assessment with a fertility specialist is important.

How is adenomyosis different from fibroids?

Fibroids are discrete, encapsulated growths of smooth muscle that can be individually identified and removed. Adenomyosis is diffuse infiltration of endometrial tissue throughout the uterine muscle — it cannot be "removed" as a discrete lesion in most cases (except in focal adenomyoma presentations). On ultrasound, distinguishing focal adenomyosis from a small fibroid can be challenging.

---

This blog is written for educational and informational purposes only. Please consult Dr. Shachi Singh or a qualified gynaecologist for an assessment specific to your situation.